Carmen Belli

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Magnetic Resonance

Top Venues

British journal of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Berton Giacchetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli, Curigliano Giuseppe
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting. Cancers 16 (2) (2024)
Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Berton Giacchetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli, Curigliano Giuseppe
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting. Cancers 16 (2) (2024)
Edoardo Crimini, Luca Boscolo Bielo, Pier Paolo Berton Giacchetti, Gloria Pellizzari, Gabriele Antonarelli, Beatrice Taurelli Salimbeni, Matteo Repetto, Carmen Belli, Curigliano Giuseppe
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting. Cancers 16 (2) (2024)
Carmen Belli, Matteo Repetto, Santosh Anand, Camillo Porta, Vivek Subbiah, Curigliano Giuseppe
The emerging role of PI3K inhibitors for solid tumour treatment and beyond. British journal of cancer (2023)
Carmen Belli, Gabriele Antonarelli, Matteo Repetto, Luca Boscolo Bielo, Edoardo Crimini, Curigliano Giuseppe
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies. Cancers 14 (17) (2022)
Pamela Trillo Aliaga, Dario Trapani, José Luis Sandoval, Edoardo Crimini, Gabriele Antonarelli, Grazia Vivanet, Stefania Morganti, Chiara Corti, Paolo Tarantino, Alex Friedlaender, Carmen Belli, Ida Minchella, Marzia Locatelli, Angela Esposito, Carmen Criscitiello, Curigliano Giuseppe
Safety of COVID-19 mRNA Vaccines in Patients with Cancer Enrolled in Early-Phase Clinical Trials. Cancers 13 (22) (2021)